Paludisme : vers un nouveau traitement !

Sharon Wein; Michèle Calas; Françoise Bressolle; Socrates Herrera; Alan Thomas; Henri Vial

doi:10.1051/medsci/2005214341

Home

All issues

Volume 21 / No 4 (Avril 2005)

Med Sci (Paris), 21 4 (2005) 341-343

References

Free Access

Issue		Med Sci (Paris) Volume 21, Number 4, Avril 2005


Page(s)		341 - 343
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/2005214341
Published online		15 April 2005

Hartl DL. The origin of malaria : mixed messages from genetic diversity. Nat Rev Microbiol 2004; 2 :15–22. [Google Scholar]
http://www.who.int/tdr/diseases/malaria/default.htm [Google Scholar]
Biagini GA, O’Neill PM, Nzila A, et al. Antimalarial chemotherapy : young guns or back to the future ? Trends Parasitol 2003; 19 : 479–87. [Google Scholar]
Kremsner PG, Krishna S. Antimalarial combinations. Lancet 2004; 364 :285–94. [Google Scholar]
Vial HJ, Ben Mamoun C. Plasmodium lipids : metabolism and function. In : Sherman IW, ed. Molecular approach to malaria. Washington DC : ASM Press, 2005 (sous presse). [Google Scholar]
Roggero R, Zufferey R, Minca M, et al. Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae. Antimicrob Agents Chemother 2004; 48 : 2816–24. [Google Scholar]
Calas M, Ancelin ML, Cordina G, et al. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism : comparison between mono- and bisquaternary ammonium salts. J Med Chem 2000; 43 : 505–16. [Google Scholar]
Wengelnik K, Vidal V, Ancelin ML, et al. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 2002; 295 : 1311–4. [Google Scholar]
Ancelin ML, Calas M, Vidal-Sailhan V, et al. Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob Agents Chemother 2003; 47 : 2590–7. [Google Scholar]
Ancelin ML, Calas M, Bonhoure A, et al. In vivo activities of mono and bis quarternary ammonium salts interfering with Plasmodium phospholipids metabolism. Antimicrob Agents Chemother 2003; 47 : 2598–605. [Google Scholar]
Vial HJ, Wein S, Farenc C, et al. Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc Natl Acad Sci USA 2004; 101 : 15458–63. [Google Scholar]
Biagini GA, Richier E, Bray P, et al.Heme binding contributes to the antimalarial activity of bis-quaternary ammonium compound. Antimicrob Agents Chemother 2003; 47 : 2584–9. [Google Scholar]
Van Dooren GG, Walker RF, Roos DS, Mc Fadden GI. Traffic jams : protein transport in Plasmodium falciparum. Parasitol Today 2000; 16 : 421–7. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.

[1] Hartl DL. The origin of malaria : mixed messages from genetic diversity. Nat Rev Microbiol 2004; 2 :15–22. [Google Scholar]

[2] http://www.who.int/tdr/diseases/malaria/default.htm [Google Scholar]

[3] Biagini GA, O’Neill PM, Nzila A, et al. Antimalarial chemotherapy : young guns or back to the future ? Trends Parasitol 2003; 19 : 479–87. [Google Scholar]

[4] Kremsner PG, Krishna S. Antimalarial combinations. Lancet 2004; 364 :285–94. [Google Scholar]

[5] Vial HJ, Ben Mamoun C. Plasmodium lipids : metabolism and function. In : Sherman IW, ed. Molecular approach to malaria. Washington DC : ASM Press, 2005 (sous presse). [Google Scholar]

[6] Roggero R, Zufferey R, Minca M, et al. Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae. Antimicrob Agents Chemother 2004; 48 : 2816–24. [Google Scholar]

[7] Calas M, Ancelin ML, Cordina G, et al. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism : comparison between mono- and bisquaternary ammonium salts. J Med Chem 2000; 43 : 505–16. [Google Scholar]

[8] Wengelnik K, Vidal V, Ancelin ML, et al. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 2002; 295 : 1311–4. [Google Scholar]

[9] Ancelin ML, Calas M, Vidal-Sailhan V, et al. Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob Agents Chemother 2003; 47 : 2590–7. [Google Scholar]

[10] Ancelin ML, Calas M, Bonhoure A, et al. In vivo activities of mono and bis quarternary ammonium salts interfering with Plasmodium phospholipids metabolism. Antimicrob Agents Chemother 2003; 47 : 2598–605. [Google Scholar]

[11] Vial HJ, Wein S, Farenc C, et al. Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc Natl Acad Sci USA 2004; 101 : 15458–63. [Google Scholar]

[12] Biagini GA, Richier E, Bray P, et al.Heme binding contributes to the antimalarial activity of bis-quaternary ammonium compound. Antimicrob Agents Chemother 2003; 47 : 2584–9. [Google Scholar]

[13] Van Dooren GG, Walker RF, Roos DS, Mc Fadden GI. Traffic jams : protein transport in Plasmodium falciparum. Parasitol Today 2000; 16 : 421–7. [Google Scholar]